Schroder Investment Management Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Schroder Investment Management Group's CLB Position: Q2 2026 in Review
Schroder Investment Management Group opened a new position in Core Laboratories (CLB) in Q2 2026: 1,543,638 shares worth $16.9M. The stake represents 0.01% of the portfolio and ranks #573 among its holdings. This is a return to the name: Schroder Investment Management Group previously reported a position in CLB as recently as Q1 2025.
Schroder Investment Management Group first reported a position in CLB in Q2 2013 and has held it in 28 quarters since. The position peaked at $38.1M in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Schroder Investment Management Group held 1,543,638 shares of Core Laboratories worth $16.9M as of Q2 2026.
- Core Laboratories was a new Schroder Investment Management Group position in Q2 2026.
- Core Laboratories made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #573 holding.
- Schroder Investment Management Group first reported a position in Core Laboratories in Q2 2013 and has held it in 28 quarters since.
- Schroder Investment Management Group's Core Laboratories position peaked at $38.1M in Q2 2018.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.